Skip to main content
. 2013 Feb 21;2013:593020. doi: 10.1155/2013/593020

Table 2.

Median dose effect analysis was also employed to characterize the interactions between DHMEQ and TMZ. For concomitant treatment, different doses of DHMEQ were combined with 250 μM TMZ and treated for 48 h. For the sequential schedule cells were exposed to different concentrations of DHMEQ, and after 6 h TMZ at the same dose was included in culture media and also analyzed at 48 h (TMZ exposure 42 h). Combination index (CI) values <1 correspond to a synergistic interaction (emphasized in bold). Dose reduction index (DRI) reflects the fold reduction in the required concentration of tested agents when used in combination to achieve the comparable affected fraction (AF).

U251 Concomitant TMZ (250 μM) Sequential TMZ (250 μM)
DHMEQ (μg/mL) AF AF CI DRI AF CI DRI
2.5 0.00 0.15 2.02 0.58 0.38 0.68 1.87
5 0.07 0.26 1.31 1.11 0.42 0.73 2.19
10 0.19 0.36 1.21 1.73 0.6 0.59 4.36
20 0.47 0.65 0.83 5.33 0.8 0.51 10.99

U343MG-a Concomitant TMZ (250 μM) Sequential TMZ (250 μM)
DHMEQ (μg/mL) AF AF CI DRI AF CI DRI

2.5 0.08 0.37 0.8 1.56 0.26 1.17 1.08
5 0.10 0.44 0.78 1.92 0.41 0.86 1.76
10 0.22 0.58 0.69 2.86 0.58 0.69 2.86
20 0.53 0.79 0.47 5.84 0.80 0.45 6.10

U138MG Concomitant TMZ (250 μM) Sequential TMZ (250 μM)
DHMEQ (μg/mL) AF AF CI DRI AF CI DRI

2.5 0.01 0.01 4.22 0.31 0.18 0.48 2.07
5 0.01 0.01 2.08 0.48 0.26 0.36 2.76
10 0.03 0.02 1.60 0.62 0.34 0.28 3.50
20 0.02 0.02 1.10 3.03 0.85 0.06 15.25

U87MG Concomitant TMZ (250 μM) Sequential TMZ (250 μM)
DHMEQ (μg/mL) AF AF CI DRI AF CI DRI

2.5 0.00 0.53 0.3 7.1 0.42 0.61 2.42
5 0.10 0.45 0.68 3.26 0.61 0.34 15.71
10 0.27 0.60 0.64 14.2 0.83 0.33 248.40
20 0.69 0.88 0.55 666.16 0.94 0.38 4197.79

T98G Concomitant TMZ (250 μM) Sequential TMZ (250 μM)
DHMEQ (μg/mL) AF AF CI DRI AF CI DRI

2.5 0.05 0.02 53.87 0.01 0.26 1.00 1.20
5 0.11 0.08 7.58 0.15 0.36 0.70 2.39
10 0.18 0.13 4.52 0.6 0.39 0.85 2.88
20 0.43 0.32 1.84 0.76 0.82 0.22 50.10

LN319 Concomitant TMZ (250 μM) Sequential TMZ (250 μM)
DHMEQ (μg/mL) AF AF CI DRI AF CI DRI

2.5 0.09 0.41 0.37 4.37 0.44 0.33 5.1
5 0.25 0.55 0.3 8.90 0.34 0.68 2.74
10 0.44 0.7 0.27 20.09 0.89 0.09 96.11
20 0.67 0.8 0.31 39.6 0.88 0.19 84.93